Dose-Ranging Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss
Condition(s):Androgenetic AlopeciaLast Updated:May 20, 2008Unknown status
Hide Studies Not Open or Pending
Condition(s):Androgenetic AlopeciaLast Updated:May 20, 2008Unknown status
Condition(s):Androgenetic AlopeciaLast Updated:May 20, 2008Completed
Condition(s):Multiple Myeloma; Refractory Multiple Myeloma; Relapsed/Refractory Multiple MyelomaLast Updated:September 8, 2023Terminated
Condition(s):Multiple MyelomaLast Updated:January 26, 2023Completed
Condition(s):Non-Small Cell Lung Cancer; Pancreatic Cancer; Melanoma; Lymphoma; Multiple MyelomaLast Updated:November 22, 2017Completed
Condition(s):Lupus Nephritis; Proteinuria; HematuriaLast Updated:April 24, 2012Withdrawn
Condition(s):Benign and Malignant Hematologic DiseasesLast Updated:May 24, 2018Active, not recruiting
Condition(s):Human Papilloma Virus; Human Immunodeficiency Virus; Anal Intraepithelial Neoplasia; High-Grade Squamous Intraepithelial LesionsLast Updated:January 31, 2024Not yet recruiting
Condition(s):Multiple MyelomaLast Updated:October 18, 2023Recruiting
Condition(s):Advanced CancersLast Updated:July 27, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.